IBDEI0LL ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1026,0)
 ;;=V CODES^23^94
 ;;^UTILITY(U,$J,358.4,1027,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^94
 ;;^UTILITY(U,$J,358.4,1028,0)
 ;;=DEPRESSION^9^94
 ;;^UTILITY(U,$J,358.4,1029,0)
 ;;=MOOD DISORDERS (OTHER)^11^94
 ;;^UTILITY(U,$J,358.4,1030,0)
 ;;=SCHIZOPHRENIA^18^94
 ;;^UTILITY(U,$J,358.4,1031,0)
 ;;=SOMATIFORM DISORDERS^21^94
 ;;^UTILITY(U,$J,358.4,1032,0)
 ;;=EATING DISORDERS^10^94
 ;;^UTILITY(U,$J,358.4,1033,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^94
 ;;^UTILITY(U,$J,358.4,1034,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^94
 ;;^UTILITY(U,$J,358.4,1035,0)
 ;;=BRAIN DISORDERS^6^94
 ;;^UTILITY(U,$J,358.4,1036,0)
 ;;=PRIMARY DIAGNOSIS^1^95
 ;;^UTILITY(U,$J,358.4,1037,0)
 ;;=NEW PATIENT^1^96
 ;;^UTILITY(U,$J,358.4,1038,0)
 ;;=ESTABLISHED PATIENT^2^96
 ;;^UTILITY(U,$J,358.4,1039,0)
 ;;=EDUCATION & TRAINING FOR SELF MANAGEMENT^3^96
 ;;^UTILITY(U,$J,358.4,1040,0)
 ;;=ADJUSTMENT DISORDERS^2^97
 ;;^UTILITY(U,$J,358.4,1041,0)
 ;;=ANXIETY DISORDERS^4^97
 ;;^UTILITY(U,$J,358.4,1042,0)
 ;;=AMNESTICS^3^97
 ;;^UTILITY(U,$J,358.4,1043,0)
 ;;=ORGANIC DISORDERS^13^97
 ;;^UTILITY(U,$J,358.4,1044,0)
 ;;=DEMENTIA^8^97
 ;;^UTILITY(U,$J,358.4,1045,0)
 ;;=DELIRIUM^7^97
 ;;^UTILITY(U,$J,358.4,1046,0)
 ;;=BIPOLAR DISORDERS^5^97
 ;;^UTILITY(U,$J,358.4,1047,0)
 ;;=PSYCHOSIS/OTHER^17^97
 ;;^UTILITY(U,$J,358.4,1048,0)
 ;;=PERSONALITY DISORDERS^15^97
 ;;^UTILITY(U,$J,358.4,1049,0)
 ;;=SEXUAL DISORDERS^19^97
 ;;^UTILITY(U,$J,358.4,1050,0)
 ;;=SLEEP DISORDERS^20^97
 ;;^UTILITY(U,$J,358.4,1051,0)
 ;;=OTHER DISORDERS^14^97
 ;;^UTILITY(U,$J,358.4,1052,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^97
 ;;^UTILITY(U,$J,358.4,1053,0)
 ;;=V CODES^23^97
 ;;^UTILITY(U,$J,358.4,1054,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^97
 ;;^UTILITY(U,$J,358.4,1055,0)
 ;;=DEPRESSION^9^97
 ;;^UTILITY(U,$J,358.4,1056,0)
 ;;=MOOD DISORDERS (OTHER)^11^97
 ;;^UTILITY(U,$J,358.4,1057,0)
 ;;=SCHIZOPHRENIA^18^97
 ;;^UTILITY(U,$J,358.4,1058,0)
 ;;=SOMATIFORM DISORDERS^21^97
 ;;^UTILITY(U,$J,358.4,1059,0)
 ;;=EATING DISORDERS^10^97
 ;;^UTILITY(U,$J,358.4,1060,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^97
 ;;^UTILITY(U,$J,358.4,1061,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^97
 ;;^UTILITY(U,$J,358.4,1062,0)
 ;;=BRAIN DISORDERS^6^97
 ;;^UTILITY(U,$J,358.4,1063,0)
 ;;=PRESCRIBER CODES^2^98
 ;;^UTILITY(U,$J,358.4,1064,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^3^98
 ;;^UTILITY(U,$J,358.4,1065,0)
 ;;=OTHER CODES^6^98
 ;;^UTILITY(U,$J,358.4,1066,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^4^98
 ;;^UTILITY(U,$J,358.4,1067,0)
 ;;=TEAM CONFERENCE^12^98
 ;;^UTILITY(U,$J,358.4,1068,0)
 ;;=INTERACTIVE COMPLEXITY^5^98
 ;;^UTILITY(U,$J,358.4,1069,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^1^98
 ;;^UTILITY(U,$J,358.4,1070,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^9^98
 ;;^UTILITY(U,$J,358.4,1071,0)
 ;;=PROLONGED SERVICES^8^98
 ;;^UTILITY(U,$J,358.4,1072,0)
 ;;=SUBSTANCE ABUSE^11^98
 ;;^UTILITY(U,$J,358.4,1073,0)
 ;;=PREVENTIVE HEALTH^7^98
 ;;^UTILITY(U,$J,358.4,1074,0)
 ;;=ESTABLISHED PATIENT^1^99
 ;;^UTILITY(U,$J,358.4,1075,0)
 ;;=CONSULTATIONS^3^99
 ;;^UTILITY(U,$J,358.4,1076,0)
 ;;=NEW PATIENT^2^99
 ;;^UTILITY(U,$J,358.4,1077,0)
 ;;=INPATIENT CONSULTATIONS^6^99
 ;;^UTILITY(U,$J,358.4,1078,0)
 ;;=INITIAL HOSPITAL CARE^7^99
 ;;^UTILITY(U,$J,358.4,1079,0)
 ;;=HOSPITAL CARE DISCHARGE SERVICES^9^99
 ;;^UTILITY(U,$J,358.4,1080,0)
 ;;=INITIAL OBSERVATION CARE^10^99
 ;;^UTILITY(U,$J,358.4,1081,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^12^99
 ;;^UTILITY(U,$J,358.4,1082,0)
 ;;=INPT/OBS ADMIT/DISCHARGE SAME DATE^13^99
 ;;^UTILITY(U,$J,358.4,1083,0)
 ;;=SUBSEQUENT HOSPITAL CARE^8^99
 ;;^UTILITY(U,$J,358.4,1084,0)
 ;;=OBSERVATION SUBSEQUESNT CARE^11^99
 ;;^UTILITY(U,$J,358.4,1085,0)
 ;;=DOM ESTABLISHED VISITS^4^99
 ;;^UTILITY(U,$J,358.4,1086,0)
 ;;=DOM NEW VISITS^5^99
 ;;^UTILITY(U,$J,358.4,1087,0)
 ;;=ADJUSTMENT DISORDERS^2^100
 ;;^UTILITY(U,$J,358.4,1088,0)
 ;;=ANXIETY DISORDERS^4^100
 ;;^UTILITY(U,$J,358.4,1089,0)
 ;;=AMNESTICS^3^100
 ;;^UTILITY(U,$J,358.4,1090,0)
 ;;=ORGANIC DISORDERS^13^100
 ;;^UTILITY(U,$J,358.4,1091,0)
 ;;=DEMENTIA^8^100
 ;;^UTILITY(U,$J,358.4,1092,0)
 ;;=DELIRIUM^7^100
 ;;^UTILITY(U,$J,358.4,1093,0)
 ;;=BIPOLAR DISORDERS^5^100
 ;;^UTILITY(U,$J,358.4,1094,0)
 ;;=PSYCHOSIS/OTHER^17^100
 ;;^UTILITY(U,$J,358.4,1095,0)
 ;;=PERSONALITY DISORDERS^15^100
 ;;^UTILITY(U,$J,358.4,1096,0)
 ;;=SEXUAL DISORDERS^19^100
 ;;^UTILITY(U,$J,358.4,1097,0)
 ;;=SLEEP DISORDERS^20^100
 ;;^UTILITY(U,$J,358.4,1098,0)
 ;;=OTHER DISORDERS^14^100
 ;;^UTILITY(U,$J,358.4,1099,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^100
 ;;^UTILITY(U,$J,358.4,1100,0)
 ;;=V CODES^23^100
 ;;^UTILITY(U,$J,358.4,1101,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^100
 ;;^UTILITY(U,$J,358.4,1102,0)
 ;;=DEPRESSION^9^100
 ;;^UTILITY(U,$J,358.4,1103,0)
 ;;=MOOD DISORDERS (OTHER)^11^100
 ;;^UTILITY(U,$J,358.4,1104,0)
 ;;=SCHIZOPHRENIA^18^100
 ;;^UTILITY(U,$J,358.4,1105,0)
 ;;=SOMATIFORM DISORDERS^21^100
 ;;^UTILITY(U,$J,358.4,1106,0)
 ;;=EATING DISORDERS^10^100
 ;;^UTILITY(U,$J,358.4,1107,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^100
 ;;^UTILITY(U,$J,358.4,1108,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^100
 ;;^UTILITY(U,$J,358.4,1109,0)
 ;;=BRAIN DISORDERS^6^100
 ;;^UTILITY(U,$J,358.4,1110,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^6^101
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^7^101
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=OTHER CODES^3^101
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^1^101
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=TEAM CONFERENCE^9^101
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=INTERACTIVE COMPLEXITY^2^101
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=SUBSTANCE ABUSE^8^101
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^5^101
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=PROLONGED SERVICE^4^101
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=TOBACCO CESSATION COUNSELING^10^101
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=ADJUSTMENT DISORDERS^2^102
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=ANXIETY DISORDERS^4^102
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=AMNESTICS^3^102
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=ORGANIC DISORDERS^13^102
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;=DEMENTIA^8^102
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;=DELIRIUM^7^102
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;=BIPOLAR DISORDERS^5^102
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;=PSYCHOSIS/OTHER^17^102
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;=PERSONALITY DISORDERS^15^102
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=SEXUAL DISORDERS^19^102
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=SLEEP DISORDERS^20^102
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=OTHER DISORDERS^14^102
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^102
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=V CODES^23^102
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^102
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=DEPRESSION^9^102
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=MOOD DISORDERS (OTHER)^11^102
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=SCHIZOPHRENIA^18^102
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=SOMATIFORM DISORDERS^21^102
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=EATING DISORDERS^10^102
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^102
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^102
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=BRAIN DISORDERS^6^102
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=OUTPT NEW PATIENT^3^103
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=OUTPT ESTABLISHED PATIENT^2^103
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=OUTPT CONSULTATIONS^4^103
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=NURSING VISIT ONLY^1^103
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=INITIAL OBSERVATION^9^103
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=SAME DAY ADM/DISCHARGE^12^103
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=INPT CONSULTATIONS^5^103
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=INITIAL HOSPITAL CARE^6^103
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=SUBSEQUENT HOSPITAL CARE^7^103
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=HOSPITAL CARE D/C SERVICES^8^103
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=SUBSEQUENT OBSERVATION CARE^10^103
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=OBSERVATION CARE D/C SERVICES^11^103
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=DIALYSIS ENCOUNTER^1^104
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^2^104
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=CARDIOLOGY^3^104
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=COMPLICATIONS/OTHER^4^104
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=CYSTIC KIDNEY DISEASE^5^104
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^104
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=FLUID/ELECTROLYTES DISORDER^7^104
 ;;^UTILITY(U,$J,358.4,1162,0)
 ;;=GENERAL SYMPTOMS^8^104
 ;;^UTILITY(U,$J,358.4,1163,0)
 ;;=GENITAL/URINARY^9^104
 ;;^UTILITY(U,$J,358.4,1164,0)
 ;;=HEMATOLOGY^10^104
 ;;^UTILITY(U,$J,358.4,1165,0)
 ;;=HYPERTENSION PRIMARY^11^104
 ;;^UTILITY(U,$J,358.4,1166,0)
 ;;=HYPERTENSION SECONDAY^12^104
 ;;^UTILITY(U,$J,358.4,1167,0)
 ;;=HYPERTENSIVE HEART/RENAL^13^104
 ;;^UTILITY(U,$J,358.4,1168,0)
 ;;=INFECTIOUS DISEASE^14^104
 ;;^UTILITY(U,$J,358.4,1169,0)
 ;;=NEPHRITIS GLOMERULONEPHRITIS^15^104
 ;;^UTILITY(U,$J,358.4,1170,0)
 ;;=NEPHRITIS INTERSTITIAL^16^104
 ;;^UTILITY(U,$J,358.4,1171,0)
 ;;=NEPHROTIC SYNDROME^17^104
 ;;^UTILITY(U,$J,358.4,1172,0)
 ;;=OBSTRUCTIVE UROPATHY/STONES^18^104
 ;;^UTILITY(U,$J,358.4,1173,0)
 ;;=ONCOLOGY^19^104
 ;;^UTILITY(U,$J,358.4,1174,0)
 ;;=TRANSPLANTATION^21^104
 ;;^UTILITY(U,$J,358.4,1175,0)
 ;;=PROLONGED SERVICES^5^105
 ;;^UTILITY(U,$J,358.4,1176,0)
 ;;=VENOUS^6^105
 ;;^UTILITY(U,$J,358.4,1177,0)
 ;;=BP MONITORING^1^105
 ;;^UTILITY(U,$J,358.4,1178,0)
 ;;=MEDICATION^4^105
 ;;^UTILITY(U,$J,358.4,1179,0)
 ;;=CARDIOVASCULAR^2^105
 ;;^UTILITY(U,$J,358.4,1180,0)
 ;;=CATHETER^3^105
 ;;^UTILITY(U,$J,358.4,1181,0)
 ;;=ESTABLISHED PATIENT^1^106
 ;;^UTILITY(U,$J,358.4,1182,0)
 ;;=CONSULTATIONS/OPINIONS^2^106
 ;;^UTILITY(U,$J,358.4,1183,0)
 ;;=NEWPATIENTS^3^106
 ;;^UTILITY(U,$J,358.4,1184,0)
 ;;=CEREBROVASCULAR DIS^2^107
 ;;^UTILITY(U,$J,358.4,1185,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^12^107
